Localized grey matter atrophy in multiple sclerosis: A meta-analysis of voxel-based morphometry studies and associations with functional disability

Neuroscience and Biobehavioral Reviews

Volumn 37, Issue 5, 2013, Pages 819-830

  Lansley, J ^a   Mataix Cols, D ^b   Grau, M ^b   Radua, J ^b,c   Sastre Garriga, J ^d  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Expanded Disability Status Scale; Grey matter volume; Meta analysis; Meta regression; Multiple sclerosis; Signed Differential Mapping; Voxel Based Morphometry

Indexed keywords

BASAL GANGLION; BRAIN ATROPHY; BRAIN MAPPING; BRAIN SIZE; CINGULATE GYRUS; DISEASE ASSOCIATION; DISEASE DURATION; FUNCTIONAL DISEASE; GRAY MATTER; HUMAN; MULTIPLE SCLEROSIS; NEUROIMAGING; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SIGNED DIFFERENTIAL MAPPING; THALAMUS; VOXEL BASED MORPHOMETRY;

ATROPHY; BRAIN; BRAIN MAPPING; DATABASES, FACTUAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MULTIPLE SCLEROSIS; NEUROIMAGING; REGRESSION ANALYSIS;

EID: 84876499601     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2013.03.006     Document Type: Review

References (71)

1. Amato M.P., Portaccio E., Goretti B., Zipoli V., Battaglini M., Bartolozzi M.L., Stromillo M.L., Guidi L., Siracusa G., Sorbi S., Federico A., De Stefano N. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Archives of Neurology 2007, 64:1157-1161.
2. Ashburner J., Friston K.J. Voxel-based morphometry - the methods. NeuroImage 2000, 11:805-821.
3. Audoin B., Davies G.R., Finisku L., Chard D.T., Thompson A.J., Miller D.H. Localization of grey matter atrophy in early RRMS: a longitudinal study. Journal of Neurology 2006, 253:1495-1501.
4. Audoin B., Zaaraoui W., Reuter F., Rico A., Malikova I., Confort-Gouny S., Cozzone P.J., Pelletier J., Ranjeva J.P. Atrophy mainly affects the limbic system and the deep grey matter at the first stage of multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 2010, 81:690-695.
5. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Current Opinion in Neurology 2002, 15:239-245.
6. Battaglini M., Giorgio A., Stromillo M.L., Bartolozzi M.L., Guidi L., Federico A., De Stefano N. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis. Journal of the Neurological Sciences 2009, 282:55-60.
7. Bendfeldt K., Egger H., Nichols T.E., Loetscher P., Denier N., Kuster P., Traud S., Mueller-Lenke N., Naegelin Y., Gass A., Kappos L., Radue E.W., Borgwardt S.J. Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis - a longitudinal MRI study. Brain Research 2010, 1325:174-182.
8. Bendfeldt K., Hofstetter L., Kuster P., Traud S., Mueller-Lenke N., Naegelin Y., Kappos L., Gass A., Nichols T.E., Barkhof F., Vrenken H., Roosendaal S.D., Geurts J.J., Radue E.W., Borgwardt S.J. Longitudinal gray matter changes in multiple sclerosis-differential scanner and overall disease-related effects. Human Brain Mapping 2012, 33:1225-1245.
9. Bendfeldt K., Kuster P., Traud S., Egger H., Winklhofer S., Mueller-Lenke N., Naegelin Y., Gass A., Kappos L., Matthews P.M., Nichols T.E., Radue E.W., Borgwardt S.J. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - a longitudinal voxel-based morphometry study. NeuroImage 2009, 45:60-67.
10. Benedict R.H., Weinstock-Guttman B., Fishman I., Sharma J., Tjoa C.W., Bakshi R. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Archives of Neurology 2004, 61:226-230.
11. Bo L., Geurts J.J.G., van der Valk P., Polman C., Barkhof F. Lack of correlation between cortical demyelination and white matter pathologic changes in multiple sclerosis. Archives of Neurology 2007, 64:76-80.
12. Bo L., Vedeler C.A., Nyland H.I., Trapp B.D., Mork S.J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. Journal of Neuropathology and Experimental Neurology 2003, 62:723-732.
13. Bodini B., Khaleeli Z., Cercignani M., Miller D.H., Thompson A.J., Ciccarelli O. Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Human Brain Mapping 2009, 30:2852-2861.
14. Brownell B., Hughes J.T. The distribution of plaques in the cerebrum in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1962, 25:315-320.
15. Calabrese M., Atzori M., Bernardi V., Morra A., Romualdi C., Rinaldi L., McAuliffe M.J., Barachino L., Perini P., Fischl B., Battistin L., Gallo P. Cortical atrophy is relevant in multiple sclerosis at clinical onset. Journal of Neurology 2007, 254:1212-1220.
16. Calabrese M., Filippi M., Rovaris M., Bernardi V., Atzori M., Mattisi I., Favaretto A., Grossi P., Barachino L., Rinaldi L., Romualdi C., Perini P., Gallo P. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study. Multiple Sclerosis 2009, 15:36-41.
17. Calabrese M., Rinaldi F., Mattisi I., Grossi P., Favaretto A., Atzori M., Bernardi V., Barachino L., Romualdi C., Rinaldi L., Perini P., Gallo P. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. Neurology 2010, 74:321-328.
18. Ceccarelli A., Jackson J.S., Tauhid S., Arora A., Gorky J., Dell'Oglio E., Bakshi A., Chitnis T., Khoury S.J., Weiner H.L., Guttmann C.R., Bakshi R., Neema M. The impact of lesion in-painting and registration methods on voxel-based morphometry in detecting regional cerebral gray matter atrophy in multiple sclerosis. American Journal of Neuroradiology 2012, 33:1579-1585.
19. Ceccarelli A., Rocca M.A., Pagani E., Colombo B., Martinelli V., Comi G., Filippi M. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. NeuroImage 2008, 42:315-322.
20. Ceccarelli A., Rocca M.A., Pagani E., Ghezzi A., Capra R., Falini A., Scotti G., Comi G., Filippi M. The topographical distribution of tissue injury in benign MS: a 3T multiparametric MRI study. NeuroImage 2008, 39:1499-1509.
21. Ceccarelli A., Rocca M.A., Valsasina P., Rodegher M., Pagani E., Falini A., Comi G., Filippi M. A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis. Human Brain Mapping 2009, 30:3009-3019.
22. Chen J.T., Narayanan S., Collins D.L., Smith S.M., Matthews P.M., Arnold D.L. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. NeuroImage 2004, 23:1168-1175.
23. Cifelli A., Arridge M., Jezzard P., Esiri M.M., Palace J., Matthews P.M. Thalamic neurodegeneration in multiple sclerosis. Annals of Neurology 2002, 52:650-653.
24. De Stefano N., Matthews P.M., Filippi M., Agosta F., De Luca M., Bartolozzi M.L., Guidi L., Ghezzi A., Montanari E., Cifelli A., Federico A., Smith S.M. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003, 60:1157-1162.
25. Duan Y., Liu Y., Liang P., Jia X., Yu C., Qin W., Sun H., Liao Z., Ye J., Li K. Comparison of grey matter atrophy between patients with neuromyelitis optica and multiple sclerosis: a voxel-based morphometry study. European Journal of Radiology 2012, 81:e110-e114.
26. Ferreira L.K., Diniz B.S., Forlenza O.V., Busatto G.F., Zanetti M.V. Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies. Neurobiology of Aging 2011, 32:1733-1741.
27. Filippi M., Rocca M.A., Barkhof F., Brück W., Chen J.T., Comi G., DeLuca G., De Stefano N., Erickson B.J., Evangelou N., Fazekas F., Geurts J.J., Lucchinetti C., Miller D.H., Pelletier D., Popescu B.F., Lassmann H. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurology 2012, 11:349-360.
28. Fisher E., Lee J.C., Nakamura K., Rudick R.A. Gray matter atrophy in multiple sclerosis: a longitudinal study. Annals of Neurology 2008, 64:255-265.
29. Fisniku L.K., Chard D.T., Jackson J.S., Anderson V.M., Altmann D.R., Miszkiel K.A., Thompson A.J., Miller D.H. Gray matter atrophy is related to long-term disability in multiple sclerosis. Annals of Neurology 2008, 64:247-254.
30. Henry R.G., Shieh M., Okuda D.T., Evangelista A., Gorno-Tempini M.L., Pelletier D. Regional grey matter atrophy in clinically isolated syndromes at presentation. Journal of Neurology, Neurosurgery and Psychiatry 2008, 79:1236-1244.
31. Huang Y., Mucke L. Alzheimer mechanisms and therapeutic strategies. Cell 2012, 148:1204-1222.
32. Hulst H.E., Geurts J.J. Gray matter imaging in multiple sclerosis: what have we learned?. BMC Neurology 2011, 11:153.
33. Khaleeli Z., Cercignani M., Audoin B., Ciccarelli O., Miller D.H., Thompson A.J. Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. NeuroImage 2007, 37:253-261.
34. Kidd D., Barkhof F., McConnell R., Algra P.R., Allen I.V., Revesz T. Cortical lesions in multiple sclerosis. Brain 1999, 122(Pt 1):17-26.
35. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
36. Li J., Zhang Z., Shang H. A meta-analysis of voxel-based morphometry studies on unilateral refractory temporal lobe epilepsy. Epilepsy Research 2012, 98:97-103.
37. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gøtzsche P.C., Ioannidis J., Clarke M., Devereaux P., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology 2009, 62:e1-e34.
38. Mesaros S., Rocca M.A., Absinta M., Ghezzi A., Milani N., Moiola L., Veggiotti P., Comi G., Filippi M. Evidence of thalamic gray matter loss in pediatric multiple sclerosis. Neurology 2008, 70:1107-1112.
39. Mesaros S., Rovaris M., Pagani E., Pulizzi A., Caputo D., Ghezzi A., Bertolotto A., Capra R., Falautano M., Martinelli V., Comi G., Filippi M. A magnetic resonance imaging voxel-based morphometry study of regional gray matter atrophy in patients with benign multiple sclerosis. Archives of Neurology 2008, 65:1223-1230.
40. Miller D.H., Barkhof F., Frank J.A., Parker G.J., Thompson A.J. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002, 125:1676-1695.
41. Minagar A., Barnett M.H., Benedict R.H., Pelletier D., Pirko I., Sahraian M.A., Frohman E., Zivadinov R. The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects. Neurology 2013, 80:210-219.
42. Morgen K., Sammer G., Courtney S.M., Wolters T., Melchior H., Blecker C.R., Oschmann P., Kaps M., Vaitl D. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. NeuroImage 2006, 30:891-898.
43. Nakao T., Radua J., Rubia K., Mataix-Cols D. Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. American Journal of Psychiatry 2011, 168:1154-1163.
44. Pagani E., Rocca M.A., Gallo A., Rovaris M., Martinelli V., Comi G., Filippi M. Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. American Journal of Neuroradiology 2005, 26:341-346.
45. Pan P.L., Song W., Shang H.F. Voxel-wise meta-analysis of gray matter abnormalities in idiopathic Parkinson's disease. European Journal of Neurology 2012, 19:199-206.
46. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., Lublin F.D., Montalban X., O'Connor P., Sandberg-Wollheim M., Thompson A.J., Waubant E., Weinshenker B., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology 2011, 69:292-302.
47. Prakash R.S., Snook E.M., Motl R.W., Kramer A.F. Aerobic fitness is associated with gray matter volume and white matter integrity in multiple sclerosis. Brain Research 2010, 1341:41-51.
48. Prinster A., Quarantelli M., Lanzillo R., Orefice G., Vacca G., Carotenuto B., Alfano B., Brunetti A., Morra V.B., Salvatore M. A voxel-based morphometry study of disease severity correlates in relapsing - remitting multiple sclerosis. Multiple Sclerosis 2010, 16:45-54.
49. Prinster A., Quarantelli M., Orefice G., Lanzillo R., Brunetti A., Mollica C., Salvatore E., Morra V.B., Coppola G., Vacca G., Alfano B., Salvatore M. Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. NeuroImage 2006, 29:859-867.
50. Radua J., Mataix-Cols D. Voxel-wise meta-analysis of grey matter changes in obsessive-compulsive disorder. British Journal of Psychiatry 2009, 195:393-402.
51. Radua J., Mataix-Cols D. Heterogeneity of coordinate-based meta-analyses of neuroimaging data: an example from studies in OCD Reply. British Journal of Psychiatry 2010, 197:77.
52. Radua J., Mataix-Cols D. Meta-analytic methods for neuroimaging data explained. Biology of Mood and Anxiety Disorders 2012, 2:6.
53. Radua J., Mataix-Cols D., Phillips M.L., El-Hage W., Kronhaus D.M., Cardoner N., Surguladze S. A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps. European Psychiatry 2012, 27:605-611.
54. Raz E., Cercignani M., Sbardella E., Totaro P., Pozzilli C., Bozzali M., Pantano P. Clinically isolated syndrome suggestive of multiple sclerosis: voxelwise regional investigation of white and gray matter. Radiology 2010, 254:227-234.
55. Raz E., Cercignani M., Sbardella E., Totaro P., Pozzilli C., Bozzali M., Pantano P. Gray-and white-matter changes 1 year after first clinical episode of multiple sclerosis: MR imaging. Radiology 2010, 257:448-454.
56. Riccitelli G., Rocca M.A., Forn C., Colombo B., Comi G., Filippi M. Voxelwise assessment of the regional distribution of damage in the brains of patients with multiple sclerosis and fatigue. American Journal of Neuroradiology 2011, 32:874-879.
57. Riccitelli G., Rocca M.A., Pagani E., Martinelli V., Radaelli M., Falini A., Comi G., Filippi M. Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis. Multiple Sclerosis 2012, 18:1027-1037.
58. Riccitelli G., Rocca M.A., Pagani E., Rodegher M.E., Rossi P., Falini A., Comi G., Filippi M. Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype. Human Brain Mapping 2011, 32:1535-1543.
59. Roosendaal S.D., Bendfeldt K., Vrenken H., Polman C.H., Borgwardt S., Radue E.W., Kappos L., Pelletier D., Hauser S.L., Matthews P.M., Barkhof F., Geurts J.J. Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability. Multiple Sclerosis 2011, 17:1098-1106.
60. Rudick R.A., Lee J.C., Nakamura K., Fisher E. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS. Journal of the Neurological Sciences 2009, 282:106-111.
61. Sailer M., Fischl B., Salat D., Tempelmann C., Schonfeld M.A., Busa E., Bodammer N., Heinze H.J., Dale A. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003, 126:1734-1744.
62. Sander D. Hirnrindenbefunde bei multipler sklerose. European Neurology 1898, 4:427-436.
63. Sastre-Garriga J., Ingle G.T., Chard D.T., Cercignani M., Ramio-Torrenta L., Miller D.H., Thompson A.J. Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain 2005, 128:1454-1460.
64. Sastre-Garriga J., Ingle G.T., Chard D.T., Ramio-Torrenta L., McLean M.A., Miller D.H., Thompson A.J. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Archives of Neurology 2005, 62:569-573.
65. Sastre-Garriga J., Ingle G.T., Chard D.T., Ramio-Torrenta L., Miller D.H., Thompson A.J. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis. NeuroImage 2004, 22:353-359.
66. Senda J., Watanabe H., Tsuboi T., Hara K., Watanabe H., Nakamura R., Ito M., Atsuta N., Tanaka F., Naganawa S., Sobue G. MRI mean diffusivity detects widespread brain degeneration in multiple sclerosis. Journal of the Neurological Sciences 2012, 319:105-110.
67. Sepulcre J., Sastre-Garriga J., Cercignani M., Ingle G.T., Miller D.H., Thompson A.J. Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. Archives of Neurology 2006, 63:1175-1180.
68. Spanò B., Cercignani M., Basile B., Romano S., Mannu R., Centonze D., Caltagirone C., Bramanti P., Nocentini U., Bozzali M. Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis. Multiple Sclerosis 2010, 16:178-188.
69. Tedeschi G., Lavorgna L., Russo P., Prinster A., Dinacci D., Savettieri G., Quattrone A., Livrea P., Messina C., Reggio A., Bresciamorra V., Orefice G., Paciello M., Brunetti A., Coniglio G., Bonavita S., Di Costanzo A., Bellacosa A., Valentino P., Quarantelli M., Patti F., Salemi G., Cammarata E., Simone I.L., Salvatore M., Bonavita V., Alfano B. Brain atrophy and lesion load in a large population of patients with multiple sclerosis. Neurology 2005, 65:280-285.
70. Viechtbauer W. Bias and efficiency of meta-analytic variance estimators in the random-effects model. Journal of Educational and Behavioral Statistics 2005, 30:261-293.
71. Wybrecht D., Reuter F., Zaaraoui W., Faivre A., Crespy L., Rico A., Malikova I., Confort-Gouny S., Soulier E., Cozzone P.J., Pelletier J., Ranjeva J.P., Audoin B. Voxelwise analysis of conventional magnetic resonance imaging to predict future disability in early relapsing-remitting multiple sclerosis. Multiple Sclerosis 2012, 18:1585-1591.